Q2 2020 Holdings
Filed 2020-08-13 | 12 holdings | $38.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Incorporated(CYTK) | COM | 23282W605 | $37.9M | 1,607,292 | 99.6% |
| Keros Therapeutics, Inc.(KROS) | COM | 492327101 | $53.6K | 1,428,071 | 0.1% |
| Kura Oncology, Inc.(KURA) | COM | 50127T109 | $21.3K | 1,307,982 | 0.1% |
| Fulcrum Therapeutics, Inc.(FULC) | COM | 359616109 | $20.7K | 1,133,948 | 0.1% |
| Vaxcyte, Inc.(PCVX) | COM | 92243G108 | $19.6K | 620,821 | 0.1% |
| Generation Bio Co.(GBIOGBX) | COM | 37148K100 | $18.0K | 857,942 | 0.0% |
| Myokardia, Inc. | COM | 62857M105 | $12.2K | 126,492 | 0.0% |
| Cymabay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $9.9K | 2,843,893 | 0.0% |
| Voyager Therapeutics, Inc.(VYGR) | COM | 92915B106 | $6.5K | 516,751 | 0.0% |
| Oric Pharmaceuticals, Inc.(ORIC) | COM | 68622P109 | $4.2K | 125,000 | 0.0% |
| Dicerna Pharmaceuticals, Inc.(DRNAUSD) | COM | 253031108 | $635 | 25,000 | 0.0% |
| Retrophin, Inc. | COM | 761299106 | $612 | 30,000 | 0.0% |